Related Experiment Video
Updated: May 16, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Multi-mode MRI-based intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) reduces
Yue-han Lin1, Min Lou, Ren-yang Zhu
1Department of Neurology, Zhejiang University School of Medicine, Hangzhou, China.
Objective:
To compare the safety of intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) in ischemic patients under the guidance of CT and multi-mode MRI.
Methods:
The clinical, laboratory, and radiologic data from 113 consecutive hyperacute ischemic patients who received intravenous rtPA therapy from June 2009 to October 2011 was retrospectively reviewed. The rate of hemorrhagic transformation (HT) and the clinical outcome between CT and multi-mode MRI was compared. Etiological subgroups were classified according to Chinese ischemic stroke subclassification (CISS).
Results:
Among 113 patients treated with intravenous rtPA, the mean age was 66 ±12 years, 74(65.5%) were man, the pretreatment National Institutes of Health Stroke Scale score (NIHSS) was 12.4 ±6.5, and time from symptom onset to therapy was 259.7 ±131.7 min. Postlytic radiological HT was found in 34 patients (30.1%). Symptomatic ICH occurred in 9 patients (8%). Logistic regression analysis suggested that multi-mode MRI was an independent predictor of reduced risk of HT.
Conclusion:
The risk of hemorrhagic complications is lower in patients receiving intravenous thrombolytic therapy with rtPA guided by multi-mode MRI than those guided by CT scan.
Insights
Multi-mode MRI guidance for intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) in ischemic stroke patients is safer. This approach reduces the risk of hemorrhagic complications compared to CT guidance.
Area of Science:
- Neurology
- Radiology
- Cardiovascular Medicine
Background:
- Intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) is a critical treatment for acute ischemic stroke.
- Accurate patient selection and monitoring are essential to minimize treatment complications.
Purpose of the Study:
- To compare the safety of rtPA therapy guided by multi-mode MRI versus CT in ischemic stroke patients.
- To evaluate the rate of hemorrhagic transformation (HT) and clinical outcomes based on imaging guidance.
Main Methods:
- Retrospective review of clinical, laboratory, and radiologic data from 113 hyperacute ischemic stroke patients treated with intravenous rtPA.
- Comparison of hemorrhagic transformation (HT) rates and clinical outcomes between CT and multi-mode MRI guidance.
- Etiological classification using the Chinese ischemic stroke subclassification (CISS).
Main Results:
- Among 113 patients, 30.1% experienced postlytic radiological HT, and 8% had symptomatic intracranial hemorrhage (ICH).
- Multi-mode MRI was identified as an independent predictor of reduced HT risk via logistic regression analysis.
- Mean age was 66 ±12 years, 65.5% were male, NIHSS score was 12.4 ±6.5, and time to therapy was 259.7 ±131.7 min.
Conclusions:
- Intravenous thrombolytic therapy with rtPA guided by multi-mode MRI is associated with a lower risk of hemorrhagic complications compared to CT guidance.
- Multi-mode MRI may offer improved safety in rtPA treatment for ischemic stroke.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Transient Ischemic Attack l: Introduction

